Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Cardiac Electrophysiology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial.JAMA. 2003; 289: 2685-2694
- Randomized trial of resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.J Am Coll Cardiol. 2008; 52: 1834-1843
- Cardiac-resynchronization therapy for the prevention of heart-failure events.N Engl J Med. 2009; 361: 1329-1338
- Cardiac -resynchronization therapy for mild-to- moderate heart failure.N Engl J Med. 2010; 363: 2385-2395
- Predictors of response to cardiac resynchronization therapy: a systematic review.Int J Cardiol. 2016; 225: 345-352
- Superresponse to cardiac resynchronization therapy.Circulation. 2014; 130: 87-90
- Redefining the classification of response to cardiac resynchronization therapy: results from the REVERSE study.JACC Clin Electrophysiol. 2021; 7: 871-880
- Durability of the survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: fate of "nonresponders.Heart Rhythm. 2014; 11: 412-416
- Evaluation, management, and outcomes of patients poorly responsive to cardiac resynchronization device therapy.J Am Coll Cardiol. 2019; 21: 2588-2603
- Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.J Am Coll Cardiol. 2009; 53: 765-773
- Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes.Eur Heart J. 2012; 17: 2181-2188
- Cardiac resynchronization therapy-heart failure (CRT-HF) clinic: a novel model of care.PLoS One. 2019; 14: e0222610
- Primary results from the smartdelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography- guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.Circulation. 2010; 122: 2660-2668
- Frequent optimization study using the QuickOpt method.Am Heart J. 2010; 159: 944-948
Weiss R. V-V Optimization in cardiac resynchronization therapy non-responders: RESPONSE-HF trial results. Abstract AB12-5, HRS 2010, Denver, Colorado.
- Applicability of the iterative technique for cardiac resynchronization therapy optimization: full-disclosure, 50-sequential-patient dataset of transmitral Doppler traces, with implications for future research design and guidelines.Europace. 2014; 16: 541-550
- Optimization of atrioventricular delay during exercise improves cardiac output in patients stabilized with cardiac resynchronization therapy.Heart. 2012; 98: 54-59
- Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.J Card Fail. 2012; 18: 845-853
- Utility of frailty assessment for elderly patients undergoing cardiac resynchronization therapy.JACC Clin Electrophysiol. 2017; 13: 1523-1533
- The impact of left ventricular size on response to cardiac resynchronization therapy.Am Heart J. 2011; 162: 646-653
- Long-term outcomes in patients with a left ejection fraction ≤15% undergoing cardiac resynchronization therapy.JACC Clin Electrophysiol. 2021; 7: 36-46
- Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis.Europace. 2012; 14: 1139-1147
- Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial.Circulation. 2011; 123: 1159-1166
- Reasons for loss of cardiac resynchronization therapy pacing insights from 32 844 patient.Circ Arrythm Electrophysiol. 2012; 5: 885-888
- Cardiac resynchronization therapy and the relationship of percent biventricular pacing to survival.Heart Rhythm. 2011; 8: 1469-1475
- Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.N Engl J Med. 2007; 357: 2461-2471
- Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.N Engl J Med. 2013; 369: 1395-1405
- Evaluating electrocardiography-based identification of cardiac resynchronization therapy responders beyond current left bundle branch block definitions.J Am Coll Cardiol. 2020; 6: 193-203
- Nonspecific intraventrciualr conduction delay: definitions, prognosis, and implictions for cardiac resynchronization therapy.Heart Rhythm. 2015; 12: 1071-1079
- Response to cardiac resynchronization therapy is determined by intrinsic electrical substrate rather then by its modifications.Int J Cardiol. 2018; 270: 143-148
- Transcatheter mitral valve repair in patients with and without cardiac resynchronization therapy.Circ Heart Fail. 2020; 13: e007293
- MitraClip in CRT non-responders with severe mitral regurgitation.Int J Cardiol. 2014; 177: 79-85
- The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non-responders: a retrospective analysis.ESC Heart Fail. 2020; 11: 4404-4407
- Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders.J Am Coll Cardiol. 2012; 60: 1531-1539
Article Info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.